Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jan;41(1):1–9. doi: 10.1038/bjc.1980.1

Is tumour radiosensitization by misonidazole a general phenomenon?

J Denekamp, D G Hirst, F A Stewart, N H Terry
PMCID: PMC2010178  PMID: 7362769

Abstract

The response of 14 mouse tumour sub-lines to the radiosensitizing action of a large single dose of misonidazole (MISO) has been assessed by regrowth delay. In 13 of these, significant enhancement of radiation effect occurred under ambient conditions, indicating sensitization of naturally hypoxic cells. The enhancement observed (SER') varied with the radiation dose, as would be predicted for a mixed oxic/hypoxic cell population. The maximum SER' in these 13 tumours did not depend on histology or regrowth rate. The 14th tumour, a slow-growing sarcoma, was not sensitized under ambient conditions, but showed marked sensitization when clamped to produce acutely hypoxic cells. This is consistent with no hypoxic cells occurring naturally in a sarcoma with a slow rate of growth. Faster-growing variants of this tumour showed radiosensitization under ambient conditions. The slow-growing carcinoma, RH, however, appears to contain hypoxic cells and did show sensitization. The cytotoxic action of MISO was compared with the radiosensitization by administering it after irradiation in 8 of the tumour lines. In 2 tumours no cytotoxicity was observed. In the rest cytotoxicity was significant, but much smaller than the sensitization observed when MISO was administered before irradiation. These regrowth-delay data have been used to calculate hypoxic fractions in 3 ways. Estimates of hypoxic fraction ranged from less than 0.1% in the slow sarcoma to greater than or equal to 30% in several tumours. There is considerable variation in the estimate, according to the technique used.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. E., Flockhart I. R., Smithen C. E., Stratford I. J., Wardman P., Watts M. E. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res. 1976 Jul;67(1):9–20. [PubMed] [Google Scholar]
  2. Asquith J. C., Watts M. E., Patel K., Smithen C. E., Adams G. E. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res. 1974 Oct;60(1):108–118. [PubMed] [Google Scholar]
  3. Brown J. M. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979 Aug;52(620):650–656. doi: 10.1259/0007-1285-52-620-650. [DOI] [PubMed] [Google Scholar]
  4. Brown J. M., Yu N. Y., Workman P. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours. Br J Cancer. 1979 Mar;39(3):310–320. doi: 10.1038/bjc.1979.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denekamp J. Cytotoxicity and radiosensitization in mouse and man. Br J Radiol. 1978 Aug;51(608):636–637. doi: 10.1259/0007-1285-51-608-636. [DOI] [PubMed] [Google Scholar]
  6. Denekamp J., Fowler J. F., Dische S. The proportion of hypoxic cells in a human tumor. Int J Radiat Oncol Biol Phys. 1977 Nov-Dec;2(11-12):1227–1228. doi: 10.1016/0360-3016(77)90140-7. [DOI] [PubMed] [Google Scholar]
  7. Denekamp J., Harris S. R. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma. Radiat Res. 1975 Feb;61(2):191–203. [PubMed] [Google Scholar]
  8. Denekamp J., McNally N. J. The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours. Br J Radiol. 1978 Sep;51(609):747–748. doi: 10.1259/0007-1285-51-609-747. [DOI] [PubMed] [Google Scholar]
  9. Denekamp J., Michael B. D., Harris S. R. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiat Res. 1974 Oct;60(1):119–132. [PubMed] [Google Scholar]
  10. Denekamp J., Stewart F. A. Sensitization of mouse tumours using fractionated X-irradiation. Br J Cancer Suppl. 1978 Jun;3:259–263. [PMC free article] [PubMed] [Google Scholar]
  11. Denekamp J. The cellular proliferation kinetics of animal tumors. Cancer Res. 1970 Feb;30(2):393–400. [PubMed] [Google Scholar]
  12. Denekamp J. The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours. Eur J Cancer. 1972 Jun;8(3):335–340. doi: 10.1016/0014-2964(72)90029-1. [DOI] [PubMed] [Google Scholar]
  13. Flockhart I. R., Large P., Troup D., Malcolm S. L., Marten T. R. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole. Xenobiotica. 1978 Feb;8(2):97–105. doi: 10.3109/00498257809060388. [DOI] [PubMed] [Google Scholar]
  14. Fowler J. F., Denekamp J. A review of hypoxic cell radiosensitization in experimental tumors. Pharmacol Ther. 1979;7(3):413–444. doi: 10.1016/0163-7258(79)90039-1. [DOI] [PubMed] [Google Scholar]
  15. Hall E. J., Miller R., Astro M., Rini F. The nitroimidazoles as radiosensitizers and cytotoxic agents. Br J Cancer Suppl. 1978 Jun;3:120–123. [PMC free article] [PubMed] [Google Scholar]
  16. Hall E. J., Roizin-Towle L. Hypoxic sensitizers: radiobiological studies at the cellular level. Radiology. 1975 Nov;117(2):453–457. doi: 10.1148/117.2.453. [DOI] [PubMed] [Google Scholar]
  17. McNally N. J., Denekamp J., Sheldon P. W., Flockhart I. R. Hypoxic cell sensitization by misonidazole in vivo and in vitro. Br J Radiol. 1978 Apr;51(604):317–318. doi: 10.1259/0007-1285-51-604-317. [DOI] [PubMed] [Google Scholar]
  18. McNally N. J., Denekamp J., Sheldon P., Flockhart I. R., Stewart F. A. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. Radiat Res. 1978 Mar;73(3):568–580. [PubMed] [Google Scholar]
  19. Pedersen J. E., Smith M. R., Bugden R. D., Peckham M. J. Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer. 1979 Apr;39(4):429–433. doi: 10.1038/bjc.1979.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sheldon P. W., Hill S. A. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice. Br J Cancer. 1977 Jun;35(6):795–808. doi: 10.1038/bjc.1977.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stratford I. J., Adams G. E. Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro. Br J Cancer. 1977 Mar;35(3):307–313. doi: 10.1038/bjc.1977.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stratford I. J., Adams G. E. The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man. Br J Radiol. 1978 Sep;51(609):745–746. doi: 10.1259/0007-1285-51-609-745. [DOI] [PubMed] [Google Scholar]
  23. Sutherland R. M. Selective chemotherapy of noncycling cells in an in vitro tumor model. Cancer Res. 1974 Dec;34(12):3501–3503. [PubMed] [Google Scholar]
  24. Thomlinson R. H., Craddock E. A. The gross response of an experimental tumour to single doses of x-rays. Br J Cancer. 1967 Mar;21(1):108–123. doi: 10.1038/bjc.1967.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yamaura H., Matsuzawa T. Tumor regrowth after irradiation; an experimental approach. Int J Radiat Biol Relat Stud Phys Chem Med. 1979 Mar;35(3):201–219. doi: 10.1080/09553007914550241. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES